Channeling by Phenotype: Does the Obesity Paradox in COPD Confound the Respiratory Benefits Attributed to GLP-1 Receptor Agonists?

Cardenas-Duran E, Lorences-Noguera H

Open source

DOI
10.1093/qjmed/hcag250
Published
2026 Sep 17
Container
QJM : monthly journal of the Association of Physicians
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/qjmed/hcag250,
  title = {Channeling by Phenotype: Does the Obesity Paradox in COPD Confound the Respiratory Benefits Attributed to GLP-1 Receptor Agonists?},
  author = {Cardenas-Duran E and Lorences-Noguera H},
  year = {2026},
  journal = {QJM : monthly journal of the Association of Physicians},
  doi = {10.1093/qjmed/hcag250},
  url = {https://doi.org/10.1093/qjmed/hcag250}
}

RIS

TY  - JOUR
TI  - Channeling by Phenotype: Does the Obesity Paradox in COPD Confound the Respiratory Benefits Attributed to GLP-1 Receptor Agonists?
AU  - Cardenas-Duran E
AU  - Lorences-Noguera H
PY  - 2026
JO  - QJM : monthly journal of the Association of Physicians
DO  - 10.1093/qjmed/hcag250
UR  - https://doi.org/10.1093/qjmed/hcag250
ER  - 

APA

E, C., & H, L. (2026). Channeling by Phenotype: Does the Obesity Paradox in COPD Confound the Respiratory Benefits Attributed to GLP-1 Receptor Agonists?. QJM : monthly journal of the Association of Physicians. https://doi.org/10.1093/qjmed/hcag250

Source records